Simon Latimer

Simon Latimer currently serves as the Chief Financial Officer at Primrose Bio, a role initiated in November 2023. Prior to this, Simon held various positions at Ligand Pharmaceuticals from August 2019 to November 2023, culminating in the role of Director of Strategic Planning & Investor Relations. Simon’s earlier career includes extensive experience at Ernst & Young, providing assurance services related to the life sciences industry, with a focus on IPOs and public company reporting. Simon also contributed to Koch Industries as an Accounting/Analyst where VBA coding was employed to enhance reporting efficiency. Simon holds a Master's degree in Accountancy and an Associate's degree in Health Economics from the University of Denver.